Immune-based therapies in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Immune-based therapies in diffuse large B-cell lymphoma

Published:2023-06-03 Issue:6 Volume:32 Page:479-493
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

McCurry Dustin¹,Flowers Christopher R.²,Bermack Casey¹

Affiliation:

1. Oncology Fellow, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA

2. Division Head Ad Interim of Cancer Medicine, Chair and Professor of the Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA

Funder

Cancer Prevention and Research Institute of Texas

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2023.2230137

Reference156 articles.

1. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

2. Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes?

3. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

4. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

5. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma;Frontiers in Immunology;2024-01-29